Profile: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,984.95INR
5:15am EST
Price Change (% chg)

Rs-1.30 (-0.04%)
Prev Close
Rs2,986.25
Open
Rs3,000.05
Day's High
Rs3,037.00
Day's Low
Rs2,962.30
Volume
5,547
Avg. Vol
17,220
52-wk High
Rs3,247.00
52-wk Low
Rs2,365.00

Search Stocks
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company’s product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, cardiovascular disease and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus and others. Revolade is for the treatment of thrombocytopenia in adults with the blood disorder chronic immune thrombocytopenic purpura. The Company has two research and development (R&D) units, which include Chemistry Research & Development and Pharmaceutical Research & Development.

Company Address

GlaxoSmithKline Pharmaceuticals Ltd

GSK HOUSE, Dr. Annie Besant Road
MUMBAI     400030
P: +9122.24959595
F: +9122.24959494

Search Stocks